Maxcyte (MXCT) Net Equity Issued and Repurchased (2021)
Maxcyte (MXCT) posted quarterly Net Equity Issued and Repurchased of -$184.3 million for Q4 2021, down 200.0% quarter-over-quarter from $184.3 million in Q3 2021.
Maxcyte (MXCT) Net Equity Issued and Repurchased (2021) Analysis & Trends
Maxcyte (MXCT) has reported Net Equity Issued and Repurchased for 1 consecutive years, with -$184.3 million the latest figure, recorded in Q4 2021.
- In Q4 2021, Net Equity Issued and Repurchased changed N/A year-over-year to -$184.3 million; the TTM figure through Dec 2021 stood at $51.8 million (changed N/A YoY), while the FY2021 annual figure was $51.8 million, up 81.36% from the prior year.
- Net Equity Issued and Repurchased declined to -$184.3 million in Q4 2021 per MXCT's latest filing, from $184.3 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $184.3 million in Q3 2021 and bottomed at -$184.3 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.77 Bn | 124.29 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.02 Bn | 109.80 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn | - |
| 9 | Steris | 23.07 Bn | 22.58 Bn | 684.20 Mn | - |
| 10 | Maxcyte | 146.35 Mn | 146.35 Mn | 5.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -184.27 Mn |
| Dec 31, 2021 | -184.27 Mn |
| Sep 30, 2021 | 184.27 Mn |
| Sep 30, 2021 | 184.27 Mn |
| Mar 31, 2021 | 51.81 Mn |
| Mar 31, 2021 | 51.81 Mn |